Featurestory from our newsletter

March 08. 2019 Market Insights

High Throughput Analytics Herald a Paradigm Shift in the Development of Biopharmaceuticals

Biopharmaceuticals have revolutionized therapies of various diseases. In particular with regard to chronical and/or severe clinical conditions like…

February 08. 2019 Market Insights

Biosimilar Drug Development – the analytical strategy is a keyfactor for your success

Biosimilar Drug Development – the analytical strategy is a keyfactor for your success

The generation of analytical data for the comparison between…

February 05. 2019 Market Insights

Outsourcing as a Key Strategy to Lower Your Costs and to Accelerate Your Product’s Launch

Outsourcing as a Key Strategy to Lower Your Costs and to Accelerate Your Product’s Launch

What makes a good partnership? Passion? Common goals?…

February 01. 2019 Market Insights

Mass Spectrometry for Early and Enclosing Host Cell Protein Identification

Powered by Protagen Protein Services: Mass Spectrometry for Early and Enclosing Host Cell Protein Identification

Mass spectrometry (MS) becomes an…

See here our latest newsletter. The company is constantly informing in E-Mail about latest technology developments,
typical applications, as well as strategic approaches in biotherapeutic development.

NEWS & EVENTS

See here our latest news and the next events where we are participating

Heilbronn, Germany and Boston, MA – April 10th, 2019 – Protagen Protein Services GmbH (PPS), a full-service contract research organization (CRO) in…

Biopharmaceuticals have revolutionized therapies of various diseases. In particular with regard to chronical and/or severe clinical conditions like…

In response to current regulatory guidance a Mass Spectrometry (MS) based Host Cell Protein (HCP) detection approach with faster, more accurate and…

Biotech Outsourcing Strategies (BOS) Basel 2019

19. - 20. June 2019
Congress Center Basel, Basel, Basel-Stadt, Switzerland. To arrange a…

Interchangeable Biosimilars: FDA Finalizes Guidance

This past week, the US Food and Drug Administration (FDA) finalized their guidance on how…

7th Annual HCP Conference

15. - 17. May 2019
Crowne Plaza LA Harbor Hotel, San Pedro, CA, USA
To arrange a meeting…

Protagen Protein Services and BioAnalytix Merge to Create Global Analytic Service Partner for Biopharmaceuticals

Interchangeable Biosimilars: FDA Finalizes Guidance

IGBA Outlines Steps Needed for a Successful Biosimilar Regulatory System

Laborhilfskraft (m/w/d)

Biologisch-Technische Assistenten (BTA), Biotechnologische Assistenten (BioTA),…

Biologisch-Technische Assistenten (BTA), Biotechnologische Assisenten (BioTA),…

Featurestory from our newsletter

High Throughput Analytics Herald a Paradigm Shift in the Development of Biopharmaceuticals

Biosimilar Drug Development – the analytical strategy is a keyfactor for your success

Outsourcing as a Key Strategy to Lower Your Costs and to Accelerate Your Product’s Launch

Mass Spectrometry for Early and Enclosing Host Cell Protein Identification

Newsletter

NEWS & EVENTS

Protagen Protein Services and BioAnalytix Merge to Create Global Analytic Service Partner for Biopharmaceuticals

High Throughput Analytics Herald a Paradigm Shift in the Development of Biopharmaceuticals

A new level of characterizing protein impurities with MS

Biotech Outsourcing Strategies (BOS) Basel 2019

Interchangeable Biosimilars: FDA Finalizes Guidance

7th Annual HCP Conference